Advertisment

The Role of Dulaglutide in Weight Management during Smoking Cessation Among Women

author-image
Ayanna Amadi
New Update
NULL

The Role of Dulaglutide in Weight Management during Smoking Cessation Among Women

Advertisment

The Challenge of Weight Gain During Smoking Cessation

Advertisment

Quitting smoking is a significant step towards improving overall health and reducing the risk of life-threatening diseases like cancer and heart disease. However, one barrier that often hinders this journey towards improved health is the fear of weight gain following smoking cessation. This fear is particularly prominent among women, who are often more concerned about weight gain than men. A recent study found a potential solution to this problem in the form of GLP-1 receptor agonist dulaglutide.

A Closer Look at the Study

The study involved women who were in the process of quitting smoking and were treated with dulaglutide. The results showed that these women were less likely to experience substantial weight gain compared to those who received a placebo. It was observed that there were no significant gender differences in relative or absolute weight change among those on either placebo or dulaglutide. However, a lower proportion of substantial weight gain was found among women on dulaglutide compared with those on placebo (1% vs. 24%). This effect was less significant in men on dulaglutide vs. those on placebo (0% vs. 5%).

Advertisment

Impact of Dulaglutide on Smoking Abstinence Rates

Interestingly, the weight loss associated with dulaglutide had no effect on abstinence rates in both men and women. The abstinence rate in men was 65%, while it was 63% in women. This suggests that while dulaglutide can effectively control weight gain in women during smoking cessation, it does not necessarily influence the success of quitting smoking itself.

Personalized Weight Control Treatment and Future Research

Advertisment

The researchers proposed that personalized weight control treatment with GLP-1 receptor agonists like dulaglutide can benefit women at a greater risk of substantial weight gain during smoking cessation. They also suggested that future research should analyze the drug's impact on both men and women who have had several failed cessation attempts.

Concluding Thoughts

Smoking cessation is a key focus area in healthcare, and understanding the role of drugs like dulaglutide in managing post-cessation weight gain opens up new avenues for more effective and personalized treatment plans. The study's findings emphasize the importance of comprehensive treatment approaches that not only aim at helping individuals quit smoking but also manage potential weight gain, particularly in women. While there are still many aspects to be explored, these initial findings provide a promising direction for future research.

Advertisment
Chat with Dr. Medriva !